SanBio currently develops the following regenerative medicines.
Major pipeline
SB623
Development for central nervous system disorders such as chromic deficits from traumatic brain injury or ischemic stroke
Pipeline
Current status under development
SanBio’s Strengths in regenerative medicine development are shown below.
